AroCell
0,545
SEK
-3,54 %
AROC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
-3,54%
+23,86%
+39,74%
+7,92%
+7,92%
+37,63%
-29,13%
-70,3%
-77,13%
AroCell specializes in oncology and bacteriology. The company has a broad product portfolio, and develops, markets and sells blood and urine sample tests that are used by hospitals and clinics. The tests are intended to provide information for the detection of diseases such as urological cancers and typhoid fever. AroCell targets patient groups in different parts of the world. The head office is in Stockholm.
Læs mereMarkedsværdi
125,55 mio. SEK
Aktieomsætning
53,22 t SEK
Omsætning
43,04 mio.
EBIT %
-138,89 %
P/E
-
Udbytteafkast, %
-
Finanskalender
19.2
2025
Årsrapport '24
7.5
2025
Delårsrapport Q1'25
15.5
2025
Generalforsamling '25
ViserAlle indholdstyper
Labbex Förvaltnings AB Increases its Ownership in AroCell
AroCell’s Tumor Marker TPS to be introduced on a leading Japanese IVD company´s new Automated CLIA Platforms in China
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools